Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis ; volume:19 ; number:1 ; day:30 ; month:12 ; year:2019 ; pages:1-4 ; date:12.2019
BMC ophthalmology ; 19, Heft 1 (30.12.2019), 1-4, 12.2019
- Urheber
-
Shinkai, Akihiro
Saito, Wataru
Hashimoto, Yuki
Ishida, Susumu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-019-1280-1
- URN
-
urn:nbn:de:101:1-2020041022383195942820
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shinkai, Akihiro
- Saito, Wataru
- Hashimoto, Yuki
- Ishida, Susumu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Etiology of idiopathic macular holes in the light of estrogen hormone
Macular Structure Recovery after Surgery for Optic Disc Pit Maculopathy
Anti-VEGF for the management of diabetic macular edema
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-retinal autoantibodies in myopic macular degeneration: a pilot study
ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Macular edema
Estrogen rescues heart failure through estrogen receptor Beta activation
The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema
Patient Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Etiology of idiopathic macular holes in the light of estrogen hormone
Macular Structure Recovery after Surgery for Optic Disc Pit Maculopathy
Anti-VEGF for the management of diabetic macular edema
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-retinal autoantibodies in myopic macular degeneration: a pilot study
ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Macular edema
Estrogen rescues heart failure through estrogen receptor Beta activation
The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema
Patient Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Etiology of idiopathic macular holes in the light of estrogen hormone
Macular Structure Recovery after Surgery for Optic Disc Pit Maculopathy
Anti-VEGF for the management of diabetic macular edema
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Anti-retinal autoantibodies in myopic macular degeneration: a pilot study
ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors
Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Macular edema
Estrogen rescues heart failure through estrogen receptor Beta activation
The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema